Lechat P, Hadjiisky P
Service de Pharmacologie, C.H.U. Pitié-Salpétrière, Paris.
Therapie. 1993 Nov-Dec;48 Spec No:665-70.
Calcic ions play a role in the initial and chronic development of atherosclerosis lesions. Demonstration of anti atherogenic properties of calcium antagonists has open a new therapeutic approach of atherosclerosis and of its complications. Mechanism of protection remains unclear but it is essentially a preventive effect requiring very early administration before onset of lesions. Several experimental studies have shown that calcium antagonists could reduce cholesterol content of arterial wall without any modification of lipid plasma or profile. Several other mechanisms have been proposed but none of them can actually explain the observed preventive effect of these drugs. The clinical relevance in human of such a preventive effect of calcium antagonists requires further investigations.
钙离子在动脉粥样硬化病变的初始和慢性发展过程中发挥作用。钙拮抗剂抗动脉粥样硬化特性的证实为动脉粥样硬化及其并发症开辟了一种新的治疗方法。保护机制尚不清楚,但本质上是一种预防作用,需要在病变发生前非常早期给药。多项实验研究表明,钙拮抗剂可降低动脉壁胆固醇含量,而不改变血脂或血脂谱。还提出了其他几种机制,但实际上没有一种能够解释这些药物所观察到的预防作用。钙拮抗剂这种预防作用在人体中的临床相关性需要进一步研究。